Prof Research published a new market report on isothermal nucleic acid amplification technology. It presents the largest 16 players in the isothermal nucleic acid amplification technology market. The report is a professional and in-depth study on the current state of the global isothermal nucleic acid amplification technology market with a focus on the Chinese market. The report provides key statistics on the market of isothermal nucleic acid amplification technology. It is a valuable source of guidance and direction for companies and individuals interested in the isothermal nucleic acid amplification technology industry.

The global isothermal nucleic acid amplification technology market was valued to be 3,087.12 million USD in 2020 due to COVID-19. The isothermal nucleic acid amplification technology production value is anticipated to have declined with a CAGR of -30.36% in the coming years to reach 352.08 million USD in 2026.

Thermo Fisher Scientific is the largest player of isothermal nucleic acid amplification technology in the world, it has a market share of 17.48% in value. It is operating in Laboratory Products & Services, Life Sciences Solutions, Specialty Diagnostics, and Analytical Instruments segments.

Abbott is the second-largest player of isothermal nucleic acid amplification technology in the world, it has a market share of 12.99% in value. Abbott’s reportable segments are Established Pharmaceutical Products, Nutritional Products, Diagnostic Products and Medical Devices

BioMérieux is the third-largest player of isothermal nucleic acid amplification technology in the world, it has a market share of 10.22% in value. BioMérieux’s reportable segments are Molecular Biology, Microbiology, Immunoassays and Industrial Applications.

Illumina is the fourth largest player of isothermal nucleic acid amplification technology in the world, it has a market share of 7.47% in value. They have one reportable segment, Core Illumina.